Direct medical costs of pediatric asthma exacerbations requiring hospital attendance in a middle-income country |
| |
| Affiliation: | 1. Department of Pediatrics, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia;2. Department of Pediatric Pulmonology and Pediatric Critical Care Medicine, School of Medicine, Universidad El Bosque, Bogota, Colombia;3. Department of Internal Medicine, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia;4. Division of Pediatrics, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile;1. Faculdade das Ciências da Vida, Universidade da Madeira, Portugal;2. Sociedade Portuguesa de Alergologia e Imunologia Clínica - SPAIC, Lisboa, Portugal;3. Instituto de Ciências Agrárias e Ambientais Mediterrânicas – ICAAM, Évora, Portugal;4. Centro de Imunoalergologia do Algarve, Portimão, Portugal;5. Allergy Center, CUF Descobertas, Lisbon, Portugal;1. Division of Pediatric Allergy and Asthma Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Sıhhiye, Ankara, 06100 Turkey;2. Division of Pediatric Allergy, Koc University School of Medicine, Istanbul, Turkey;1. Faculty of Life Sciences and Biotechnology, Shahid Beheshti University G.C., Tehran, Iran;2. Student Research Committee, Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran;3. Department of Pediatrics, Shahid Beheshti University of Medical Sciences, Tehran, Iran;4. Mofid Children’s Hospital, Pediatrics Infectious Research Center (PIRC), Shahid Beheshti University of Medical Sciences, Tehran, Iran;5. Department of Cell and Molecular Biology, School of Biology, Faculty of Science, University of Tehran, Tehran, Iran |
| |
| Abstract: | Introduction and objectivesWith the aim of making informed decisions on resource allocation, there is a critical need for studies that provide accurate information on hospital costs for treating pediatric asthma exacerbations, mainly in middle-income countries (MICs). The aim of the present study was to evaluate the direct medical costs associated with pediatric asthma exacerbations requiring hospital attendance in Bogota, Colombia.Patients and methodsWe reviewed the available electronic medical records (EMRs) for all pediatric patients who were admitted to the Fundacion Hospital de La Misericordia with a discharge principal diagnosis pediatric asthma exacerbation over a 24-month period from January 2016 to December 2017. Direct medical costs of pediatric asthma exacerbations were retrospectively collected by dividing the patients into four groups: those admitted to the emergency department (ED) only; those admitted to the pediatric ward (PW); those admitted to the pediatric intermediate care unit (PIMC); and those admitted to the pediatric intensive care unit (PICU).ResultsA total of 252 patients with a median (IQR) age of 5.0 (3.0–7.0) years were analyzed, of whom 142 (56.3%) were males. Overall, the median (IQR) cost of patients treated in the ED, PW, PIMC, and PICU was US$38.8 (21.1–64.1) vs. US$260.5 (113.7–567.4) vs. 1212.4 (717.6–1609.6) vs. 2501.8 (1771.6–3405.0), respectively: this difference was statistically significant (p < 0.001).ConclusionsThe present study helps to further our understanding of the economic burden of pediatric asthma exacerbations requiring hospital attendance among pediatric patients in a MIC. |
| |
| Keywords: | Asthma attack Direct cost items Health economics Hospitalization costs Length of stay |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
